PMID- 28260421 OWN - NLM STAT- MEDLINE DCOM- 20180315 LR - 20180315 IS - 1477-0970 (Electronic) IS - 1352-4585 (Linking) VI - 23 IP - 3 DP - 2017 Mar TI - Successful pregnancy after natalizumab-associated progressive multifocal leukoencephalopathy in a patient with multiple sclerosis. PG - 483-486 LID - 10.1177/1352458516678475 [doi] AB - We report the case of a post-progressive multifocal leukoencephalopathy (PML), multiple sclerosis (MS) patient with an uncomplicated pregnancy and delivery. A 28-year-old woman on natalizumab (total of 49 infusions) was diagnosed with PML due to typical magnetic resonance imaging (MRI) and clinical presentation. John Cunningham virus (JCV) was detected in the cerebrospinal fluid (CSF) during the immune reconstitution inflammatory syndrome (IRIS). Nine months after PML onset, JCV negativity in the CSF was observed. MS was stabilised with dimethyl fumarate (DMF), and 18 months later, a desired pregnancy was reported, resulting in the birth of a healthy boy. Our report gives new hope regarding family planning for post-PML patients. FAU - Pitarokoili, Kalliopi AU - Pitarokoili K AD - Department of Neurology, St. Josef Hospital, Ruhr-University of Bochum, Bochum, Germany. FAU - Hellwig, Kerstin AU - Hellwig K AD - Department of Neurology, St. Josef Hospital, Ruhr-University of Bochum, Bochum, Germany. FAU - Lukas, Carsten AU - Lukas C AD - Institute of Diagnostic and Interventional Radiology, St. Josef Hospital, Ruhr-University of Bochum, Bochum, Germany. FAU - Gold, Ralf AU - Gold R AD - Department of Neurology, St. Josef Hospital, Ruhr-University of Bochum, Bochum, Germany. LA - eng PT - Case Reports PT - Journal Article DEP - 20161112 PL - England TA - Mult Scler JT - Multiple sclerosis (Houndmills, Basingstoke, England) JID - 9509185 RN - 0 (Natalizumab) SB - IM CIN - Mult Scler. 2017 Mar;23(3):486-487. PMID: 28260414 MH - Adult MH - Female MH - Humans MH - JC Virus MH - Leukoencephalopathy, Progressive Multifocal/*chemically induced/diagnosis MH - Multiple Sclerosis/complications/*drug therapy MH - Natalizumab/*adverse effects/therapeutic use MH - Pregnancy MH - Pregnancy Outcome OTO - NOTNLM OT - Multiple sclerosis OT - natalizumab EDAT- 2017/03/07 06:00 MHDA- 2018/03/16 06:00 CRDT- 2017/03/07 06:00 PHST- 2017/03/07 06:00 [entrez] PHST- 2017/03/07 06:00 [pubmed] PHST- 2018/03/16 06:00 [medline] AID - 10.1177/1352458516678475 [doi] PST - ppublish SO - Mult Scler. 2017 Mar;23(3):483-486. doi: 10.1177/1352458516678475. Epub 2016 Nov 12.